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A B S T R A C T
Here we describe our unprecedented approach in proposing parsley as a nutraceutical in-
tervention in inflammatory bowel disease (IBD) via multi-omics evaluation using dextran
sodium sulphate (DSS)-induced colitis. Seven-week-old male C57BL/6J mice were fed either
2% parsley or basal diet and drank normal-drinking-water for 1 week after which colitis was
induced by administering 1.5% (w/v) DSS-drinking-water for 9 days. Parsley supplementa-
tion significantly improved colon shortening and increased disease activity index. Colonic
transcriptome revealed down-regulation of inflammatory cytokines, hepatic transcriptome
and metabolome revealed up-regulation of fatty-acid synthesis genes, thereby improving
body weight loss. Down-regulated cancer markers were observed in the hepatic transcriptome
and proteome. Plasma metabolite analysis indicated shifts in the citric and urea cycle, im-
plicating improved impaired glycolysis and oxidative stress. Parsley’s role in preventing against
IBD was highlighted by this pioneering multi-integrated-omics which is expected to be useful
and informative, and shape the future of nutraceutical and functional food research.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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1. Introduction
Inflammatory bowel disease (IBD) includes Crohn’s disease and
ulcerative colitis which are chronic, remittent or progressive
immunologically mediated disorders that affect the entire gas-
trointestinal tract or the colonic tract, respectively (Khor, Gardet,
& Xavier, 2011). The precise etiology of IBD is unknown, but it
is increasingly clear that IBD is a complex multifactorial disease
involving genetic predisposition, intestinal microbiota, envi-
ronmental factors (including diet) and the immune system
(Baumgart & Carding, 2007). Many IBD patients have been re-
ported to become dependent and cannot be withdrawn from
treatment without a return of symptoms.Therefore, there are
needs for better therapeutic agents that can effectively induce
remission and alter the natural course of the disease with
minimum or no side effects.
Parsley (Petroselinum crispum, PAR), a biennial plant native
to Europe and Western Asia, is used as a culinary herb, con-
diment and garnish because of its special aroma; it is used on
meat, fish, and vegetables, and in marinades, sauces and stuff-
ing (Simon & Quinn, 1988). PAR contains abundant antioxidants
(luteolin and apigenin) (Justesen, Knuthsen, & Leth, 1998), folic
acid, and vitamins K, C, and A. Traditionally, PAR leaves have
been used in the treatment of inflammatory conditions, mas-
titis, hematomata, constipation, flatulence, jaundice, colic,
edema, rheumatism, as well as diseases of the prostate and
liver (Simon & Quinn, 1988).
In the present study, using a nutrigenomics approach—
the goal of which is to understand nutrients as dietary signals
that influence gene and protein expressions and subse-
quently, metabolite production—we sought to identify the
dietary signature of PAR interactions and to uncover poten-
tial novel mechanisms in a dextran sodium sulphate (DSS)-
induced colitic murine model by conducting global
transcriptome, proteome andmetabolome analyses using colon
tissue, liver tissue and plasma.
2. Materials and methods
2.1. Animals and dietary treatment
Seven-week-oldmale C57BL6/J mice obtained from Charles River
Japan (Tokyo, Japan) were housed individually in animal cages
in a room with controlled temperature (23 ± 2 °C), humidity
(50 ± 10%), and lighting (lights on from 08:00 to 20:00). After 3
days of acclimatization, the mice were divided into three groups
(n = 7) with equal mean body weights: (1) mice given a AIN-
93G basal diet and normal drinking water for the course of the
entire experiment (CON group), (2) mice given theAIN-93G basal
diet and normal drinking water for 1 week, after which colitis
was induced by administering 1.5% (w/v) DSS (DSS molecular
weight, 40 KDa; MP Biomedicals, Irvine, CA, USA)-containing
drinking water (DSS group); and (3) mice given a 2% freeze-
dried PAR powder (House Foods Group Inc., Tokyo, Japan)-
supplemented AIN-93G basal diet and normal drinking water
for 1 week, then 1.5% DSS-containing drinking water (DSSPAR
group) for 9 days. The 2% PAR diet was adjusted with corn-
starch tomaintain caloric balance as shown in Table 1.We chose
a 2% PAR supplemented diet in this study based on previous
results of a dose-dependent study. Animal care and treat-
ment were conducted in accordance with the institutional
guidelines of the University of Tokyo (Approval Number: P13-
739).
2.2. Evaluation of the disease activity index
The body weight, stool consistency and fecal blood of the mice
were recorded daily after the induction of colitis. The disease
activity index (DAI) was calculated by combining these three
scores and then dividing the score by 3. Each score was de-
termined as follows: change in body weight (0: <1%; 1: 1–5%;
2: 5–10%; 3: 10–15%; 4: >15%), fecal blood (0: no fecal blood ob-
served, 2: ++, 4: +++) and stool consistency (0: normal, 2: soft,
4: diarrhea) (Islam et al., 2009; McHenga, Wang, Li, Shan, & Lu,
2008).
2.3. Blood collection and tissue harvesting
At the time of sacrifice, the mice were deeply anesthetized with
sodium pentobarbital followed by bleeding from the carotid
artery. Plasma was obtained by centrifuging blood at 1000 × g
for 15 min at 4 °C. Colon length was measured as the dis-
tance between the ileo-cecal junction and the proximal rectum.
Excised colon tissue, liver tissue andmesenteric adipose tissues
were snap-frozen in liquid nitrogen and stored at −80 °C until
further analysis.
2.4. Biochemical assays
Colonic myeloperoxidase activity (MPO) was measured
coloriometrically (BioVision Inc., CA, USA) and concentra-
tions of plasma IL6, plasma serum amyloid A1 (SAA1) and
plasma matrix metalloproteinase-3 (MMP3) were measured by
using the ELISA (Thermo Scientific, Rockford, IL, USA; Cusabio
Biotech Co., Ltd., Hubei, China; and R&D Systems Inc., Minne-
apolis, MN, USA, respectively), according to manufacturer’s
instructions.
2.5. Colon histology
Part of the colon was embedded in Optimal Cutting Tempera-
ture compound (Sakura Finetek, Torrance, CA, USA), and then
Table 1 – Composition of diet.
Formula AIN-93G
basal diet
2%
Parsley
Ingredients (%)
Ground parsley powder – 2
Casein 20 20
Cornstarch 39.75 37.75
Detrinized cornstarch 13.2 13.2
Sucrose 10.25 10.25
Soybean oil 7 7
Fiber 5 5
Mineral mix 3.5 3.5
Vitamin mix 1 1
L-Cystine 0.3 0.3
Energy (kJ) 1559.5 1557.1
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snap-frozen in liquid nitrogen. The tissues were sectioned at
5-µm-thick and stained with hematoxylin and eosin (H&E), and
then scanned by light microscopy (200× , Olympus BX51 mi-
croscope, Olympus Optical, Tokyo, Japan).
2.6. Total RNA extraction and quality assessment
Total RNA was extracted from the frozen liver and colon
samples using the total RNA Isolation Kit, NucleoSpin® RNA
Π (Macherey-Nagel, Düren, Germany) andTrizol (Jia et al., 2013;
Jia, Takahashi, Saito, & Kato, 2013), respectively, according to
the manufacturers’ instructions. The RNA concentration and
purity were determined using a NanoDrop ND-1000 spectro-
photometer (NanoDrop Technologies, Wilmington, DE, USA).
RNA purity was assessed by using the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). RNA integrity
numbers were higher than 8.0.
2.7. Transcriptome analysis
2.7.1. DNA microarray preparation
Total hepatic and colonic RNA from each respective group were
pooled (n = 7). The microarray analysis was carried as out as
described previously in Jia et al. (2013). Mouse Genome 430 2.0
Array GeneChips (Affymetrix, Santa Clara, CA, USA) contain-
ing over 30,000 gene probe sets were used for genome-wide
expression profiling.
2.7.2. Mapping and ingenuity pathway functional analysis
The scanned images were analyzed with Microarray Suite
version 5.0 (Affymetrix) for comparing gene expression ratios
between the CON vs. DSS or DSS vs. DSSPAR groups. Genes
showing expression ratios between treatments of more than
1.5-fold were considered differentially expressed.These genes
were then selected and mapped using the Pathway Explorer
function of Ingenuity Pathway Analysis (IPA, http://
www.ingenuity.com/, date accessed: May 2013).
2.8. Reverse transcription polymerase chain reaction
RT-PCR was carried out as reported in Jia et al. (2013). Primer
sequences are as shown in Supplementary Table S1. The rela-
tive amounts of mRNAwere normalized to 60S acidic ribosomal
protein P1 (Rplp1) expression levels in each sample, and the
data are presented as the fold change of normalized mRNA
amounts of each sample to those of the DSS group.
2.9. Protein preparation, iTRAQ labeling and NanoLC-
MS/MS analysis for proteome analysis
Total protein was extracted by using lysis buffer and sepa-
rated by centrifugation at 12,000 × g for 30 min at 4 °C. Protein
concentrations were determined using the Bradford assay.
Pooled protein (100 µg) were treated for cysteine blocking and
digested, then labeled with the isobaric tag for relative and ab-
solute quantitation (iTRAQ) tags as follows: CON, 114 tag; DSS,
115 tag; DSSPAR, 116 tag, according to the manual of the 4-plex
iTRAQ labeling kit (AB SCIEX, Framingham, MA, USA). The re-
constituted samples (50 µL) were used for NanoLC-MS/MS
analysis (AB SCIEX).
2.10. Metabolome analysis
The liver samples were subjected to capillary electrophoresis–
time of flight-mass spectrometry (CE–TOFMS) and capillary
electrophoresis-triple quadrupole mass spectrometry (CE–
QqQMS) analyses, and the plasma samples were subjected to
CE–TOFMS analysis (Agilent, Palo Alto, CA, USA) as described
by Soga et al. (Soga et al., 2002, 2003).We performed a princi-
pal component analysis (PCA) with SampleStat ver. 3.14.
Normalized metabolomics data were hierarchically clustered
on both the metabolite and sample axes for a heat map rep-
resentation and further analyzed by PCA using MeV software
(Human Metabolome Technologies).
2.11. Statistical analysis
The results are presented as mean value ± standard error (SE).
Data were analyzed using one-way analysis of variance
(ANOVA), and significant differences of means were evalu-
ated with Dunnett’s test at the level of *p < 0.05; **p < 0.01 vs.
DSS group or #p < 0.05; ##p < 0.01 vs. CON group. DAI was evalu-
ated using non-parametric methods: the Kruskal–Wallis and
Steel’s test at the same level.
3. Results
3.1. General characteristics
No significant differences among the three groups were ob-
served in total food intake (CON: 60.3 ± 1.0; DSS: 60.2 ± 5.1;
DSSPAR: 60.3 ± 2.6 g), water intake (CON: 26.5 ± 0.6 mL), or DSS
intake (DSS: 24.2 ± 1.5; DSSPAR: 25.1 ± 1.3 mL). DSS adminis-
tration was associated with significant clinical changes,
including weight loss (Fig. 1A) and the appearance of occult
fecal blood and diarrhea, resulting in a significant increase in
DAI compared to the CON group (Fig. 1B). PAR supplementa-
tion suppressed these pathological conditions of IBD, resulting
in significant amelioration of DAI on day 8 and day 9 (Fig. 1B).
The DSS mice had significantly shorter colon lengths (Fig. 1C)
and lower relative mesenteric fat weight (Fig. 1D) compared
to the CON mice, and PAR significantly ameliorated these
decreases.
3.2. Biochemical analysis
The IL6 plasma levels were significantly increased by DSS ad-
ministration, and PAR supplementation attenuated this increase
(Fig. 1E). Plasma levels of SAA1 was also significantly (p = 0.01)
lower in DSSPAR (33.5 ± 3.8 ng/mL) than DSS (47.5 ± 6.8 ng/
mL) group. Significantly elevated plasma MMP3 concentrations
were observed in DSS group (4.6 ± 0.2 ng/mL) as compared to
CON (3.6 ± 0.2 ng/mL) group, however, PAR intervention strongly
tended to lower this increase (4.0 ± 0.3 ng/mL; p = 0.06).
3.3. Colon histology
DSS induced a significant loss of crypts and the infiltration
of inflammatory cells into the mucosa and submucosa
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compared to the CON group. In the DSSPAR group, PAR supple-
mentation mitigated the loss of crypts and tended to reduce
the infiltration of inflammatory cells into the colonic mucosal
wall (Fig. 1F).
3.4. Colonic microarray analysis
Among the total analyzed genes to identify colonic gene ex-
pressions associated with DSS administration and PAR
supplementation, 2189 genes were differentially expressed in
the DSS mice compared to the CON group. In the DSSPAR
groups, 125 genes were up-regulated and 235 genes were down-
regulated compared to the DSS group.The list of differentially
changed genes is further detailed in Supplementary Table S2.
PAR down-regulated the gene expression levels of the fol-
lowing members of the matrix metalloproteinase (MMP) family,
which are involved in the breakdown of the extracellular matrix
and tissue remodeling in normal physiological processes and
disease progression:Mmp3,Mmp10,Mmp13,Mmp 19 and tissue
inhibitor of metalloproteinase 1 (Timp1). The expression levels
of the following chemokines, members of the chemokine (C-
X-Cmotif) ligand (Cxcl) family, were also decreased: Cxcl1, Cxcl3,
Cxcl5, Cxcl6, Cxcl9 and Cxcl12 and chemokine (C-C motif) ligand
(Ccl): Ccl11 and Ccl5.
In addition, decreases in the expression levels of the fol-
lowing proinflammatory cytokines: secreted phosphoprotein
1 (Spp1), and members of the IL family were observed: IL1r1,
IL6 and IL6st. Other down-regulated genes included haptoglo-
bin (Hp), which plays a vital role in the susceptibility to IBD
and DSS-induced murine colitis (Marquez et al., 2011);
prostaglandin-endoperoxide synthase 2 (Ptgs2), a key factor in
inflammatory cellular response; and cluster of differentia-
tion163 (Cd163) which is commonly expressed in IBD patients
(Franzè et al., 2013). From the results of the validation by real-
time RT-PCR (Fig. 2), DSS significantly up-regulated the
expression ofMmp10, Timp1, Cxcl1, Cxcl9,Hp and Il6 and tended
the increase the expression of Mmp13,Mmp3, Ccl5, Cxcl6, Spp1
and Cd163. PAR supplementation significantly attenuated the
increases in Mmp3, Mmp10, Hp, Il6, Timp1, Ccl5 and Cd163 and
tended to suppress the up-regulation of Cxcl1, Cxcl6, Cxcl9,
Mmp13, Spp1 and Ptgs2.
3.5. Hepatic microarray analysis
Among the total analyzed genes in liver, 2219 were differen-
tially expressed in the DSS group compared to the CON mice.
In the DSSPAR group, 294 genes were up-regulated and 292
genes were down-regulated compared to the DSSmice.We have
appended the list of differentially changed genes in
Supplementary Table S3.
PAR supplementation decreased the gene expression mol-
ecules involved in macrophage and lymphocyte signaling:
vascular cell adhesion protein 1 (Vcam1), and that of the cancer
markers serum amyloid A1 (Saa1), c-Jun (Jun) and S100 calcium
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(D) relative mesenteric fat weight; (E) plasma IL6 levels; (F) H&E staining of colon. All values expressed as mean ± SE (n = 7)
(*p < 0.05; **p < 0.01 vs. DSS group; #p < 0.05; ##p < 0.01 vs. CON group by Dunnett’s test).
441j o u rna l o f f un c t i ona l f o od s 1 1 ( 2 0 1 4 ) 4 3 8 – 4 4 8
*p=0.08
0
0.5
1
1.5
CON DSS DSSPAR
R
el
at
iv
e 
Cx
cl
1
E
xp
re
ss
io
n
Cxcl1
*
*
0
0.5
1
1.5
CON DSS DSSPAR
R
el
at
iv
e 
M
m
p1
0 E
xp
re
ss
io
n
Mmp10
*
*
0
0.5
1
1.5
CON DSS DSSPAR
R
el
at
iv
e 
M
m
p3
E
xp
re
ss
io
n
Mmp3
p=0.07 p=0.08
0.0 
0.5 
1.0 
1.5 
2.0 
CON DSS DSSPAR
R
el
at
iv
e 
M
m
p1
3 E
xp
re
ss
io
n
Mmp13
*
p=0.07
0.0 
0.5 
1.0 
1.5 
CON DSS DSSPAR
R
el
at
iv
e 
C
xc
l9
E
xp
re
ss
io
n
Cxcl9
p=0.1
*
0.0 
0.5 
1.0 
1.5 
CON DSS DSSPAR
R
el
at
iv
e
C
cl
5 
E
xp
re
ss
io
n
Ccl5
p=0.05
0
0.5
1
1.5
CON DSS DSSPAR
R
el
at
iv
e 
Cx
cl
6
E
xp
re
ss
io
n 
Cxcl6
* *
0.0 
0.5 
1.0 
1.5 
CON DSS DSSPAR
R
el
at
iv
e 
H
p
E
xp
re
ss
io
n
Hp
# ##
##
##
##
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binding protein A8 (S100A8). Genes involved in the urea cycle,
i.e., argininosuccinate lyase (Oat) and arginase (Arg1), were
down-regulated. In addition, the following genes involved in
the citric acid cycle were up-regulated: phospholipase A2 (Pla2g),
stearoyl-CoA desaturase-1 (Scd1), ELOVL family member 6, elon-
gation of long chain fatty acids (Elovl6), fatty acid synthase (Fas),
malate dehydrogenase 1 (Mdh1) and NADP-dependent malic
enzyme (Me1). The gene expression level of methionine
adenosyltransferase II, alpha (Mat2a), which is involved in the
methionine recycling pathway was increased, and that of
glutamic-oxaloacetic transaminase 1 (Got1), which is in-
volved in the oxaloacetate–aspartate shuttle was decreased.
According to the results of real-time RT-PCR, we found that DSS
significantly regulated the expressions and PAR supplemen-
tation significantly mediated the expression of Arg1, Elovl6, Fas,
Got1, Jun, Mat2a, Me1, Scd1 and S1008 (Fig. 3).
3.6. Comparative proteomics analysis by iTRAQ
We included a 1.2- or 0.8-fold cut-off from 895 unique pro-
teins quantified at more than a 95% confidence level when
classifying proteins as significantly up- or down-regulated. Ac-
cording to this criterion, we screened 222 proteins, of which
99 proteins were down-regulated and 123 proteins were up-
regulated in DSSPAR compared to the DSS group
(Supplementary Table S4).
PAR supplementation down-regulated the expression levels
of the following: cancer-related proteins: protein S100-A11, Bcl-
2-like protein 1, myeloid-associated differentiation marker,
serum amyloid A-2 protein, cell death regulator aven, cullin-
4B, periplakin, serum amyloid A-1 protein and serum amyloid
P-component; diarrhea-related proteins: aquaporin 9;
fibronective proteins: collagen alpha-1(I) chain and collagen
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Fig. 2 – (continued)
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alpha-2(VI) chain; proteins involved in fatty acid oxidation:
sphingomyelin phosphodiesterase 3, sphingosine-1-phosphate
phosphatase 1, malectin, serine/threonine-protein phospha-
tase 4 regulatory subunit 3A; gamma-butyrobetaine
dioxygenase; urea cycle proteins: asparaginyl-tRNA synthe-
tase cytoplasmic; and proteins involved in glycolysis: alpha-
amylase 1, succinate dehydrogenase assembly factor 1, and
cystathionine gamma-lyase, a key protein in the methionine-
recycling pathway.
The up-regulated proteins in the DSSPAR group include pro-
teins that are involved in the citric cycle: NADP-dependentmalic
enzyme, NADH dehydrogenase [ubiquinone] flavoprotein 3,mi-
tochondrial, glutathione S-transferase P1; proteins involved in
the urea cycle: ornithine aminotransferase, mitochondrial, glu-
tathione S-transferase P1, glutamine synthetase, and
methionine-R-sulfoxide reductase B1, an enzyme of the
methionine-recycling pathway.
3.7. Plasma and hepatic metabolome evaluation
We analyzed the metabolic profiles of liver and plasma in mice
of the CON, DSS and DSSPAR groups where 116 and 127 me-
tabolites were measured, respectively.
Distinct differences among the groups were observed in the
heatmap and PCA of both plasma and liver metabolites (Fig. 4A,
B).Twenty-fivemetabolites in plasma and 24metabolites in liver
were significantly regulated by DSS administration and sub-
sequently improved by PAR supplementation (Supplementary
Table S5 for plasma and Supplementary Table S6 for liver).These
metabolites include essential and non-essential amino acids
(AA): asparagine (Asn), aspartic acid (Asp), alanine (Ala), serine
(Ser), threonine (Thr), methionine (Met), valine (Val), and iso-
leucine (Ile); and elements of the urea cycle: urea, orthinine,
arginine and intermediates of themethionine-recycling pathway
including cystathionine. The data of the hepatic total glu-
related AA, total AA, total pyr-related AA, total glucogenic AA,
total non-essential AA and the NADH/NAD+ ratio also indi-
cated that the PAR supplementation improved enhanced
glycolysis and lactate fermentation, which is common in in-
flamed environments.
4. Discussion
Inflammatory responses in the colon begin with an infiltra-
tion of neutrophils andmacrophages (Xavier & Podolsky, 2007),
and that activated macrophages produce a potent mixture of
broadly active inflammatory cytokines, including IL6, IL1 and
tumor necrosis factor-alpha (TNF-α) (Podolsky, 2002). In DSSPAR
group, the heightened inflammatory spurt and secretion of
metalloproteinases were muted by PAR supplementation, as
the global colon gene expression and RT-PCR validation re-
vealed a significant down-regulation of IL6 and its downstream
Cd163 antigen, Mmp10 and Hp. The expression of IL6st, the
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Fig. 3 – Hepatic mRNA expressions of genes related to cancer markers, genes involved in the citric cycle, urea cycle and
methionine recycling pathway and fatty acid synthesis genes. The relative mRNA expressions of Arg1, Elovl6, Fas, Got1, Jun,
Mat2, Me1, Scd1 and S100A8 were measured by RT-PCR and normalized to Rplp1. All values expressed as mean ± SE (n = 7)
(*p < 0.05; **p < 0.01 vs. DSS group; #p < 0.05; ##p < 0.01 vs. CON group by Dunnett’s test).
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regulator of Hp and IL6, and Ccl5, CCAAT/enhancer binding
protein (C/EBP),delta (Cebp/d) andMmp3, the regulators ofMmp10,
were also significantly reduced with PAR supplementation.
The expression of Hp, which is commonly upregulated in
IBD patients (Marquez et al., 2011), has been described as a
marker of inflammation due to its antioxidative properties.The
transcriptional activation of the Hp by IL6 results in the acti-
vation of C/EBP (Ramji, Vitelli, Tronche, Cortese, & Ciliberto,
1993), which was similarly observed in our study (DSS:
0.8 ± 0.3; DSSPAR: 0.2 ± 0.1; DSSPAR vs. DSS p < 0.05). Coupled
with lowered IL6 gene expression, plasma IL6 levels were also
significantly lowered by the PAR supplementation, indicating
lowered systemic inflammation. Matrix metalloproteinases, in
particularMmp3, are capable of degrading a broad range of ex-
tracellular components (Stetler-Stevenson, 1990), which may
lead to the degradation of the mucosal wall in IBD patients
(Bailey et al., 1994). In addition to a significant decrease inMmp3
gene expression levels, lower plasma MMP3 concentrations in
PAR couple the results of colon transcriptome showing that type
IX, type X and type XI collagens, laminin and fibronectin were
all differentially up-regulated in the DSS group and down-
regulated in the DSSPAR group. The mitigation of the
degradation of colon mucosal crypt walls observed in the PAR-
supplementedmice may be due, in part, to the down-regulation
ofmetalloproteinases. In addition,Timp1was significantly down-
regulated, and this was also observed in its downstream target,
IL1r1.The expression levels of Mmp13 where its upstream regu-
lator is Timp1, and Cxcl9, the downstream molecule of IL1r1,
tended to be reduced by PAR intervention. These results indi-
cate that PAR supplementation significantly ameliorated the
inflammation in the colon, which may prevent the degrada-
tion of the mucosal wall.
Direct downstream targets of released endotoxins and bac-
terial infection, the reason of accelerated DSS-induced colitis
(Chen et al., 2008), including proinflammatory cytokines such
as ILs and TNFα, can also suppress the expression of SCD1 in
the liver which has been identified and characterized as an early
event prior to IBD clinical symptoms (Chen et al., 2008). Since
in the present study the expression levels of IL6, Cxcl1, Cxcl6,
Cxcl9, and Ccl5 were dramatically increased by DSS treat-
ment, it is likely that a portal vein delivery of inflammatory
markers from the colon may contribute to the suppression of
Fig. 4 – Normalized metabolomics data were hierarchically clustered on both the metabolite and sample axes for a heat
map representation and further analyzed by PCA using MeV software. Distinct differences among the groups were observed
in the heatmap and PCA analysis of both (A) plasma and (B) liver metabolites.
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Scd1 expression in liver. PAR supplementation down-regulated
colonic cytokine expression, leading to a decrease in cytokines
delivered to the liver thereby resulting in the up-regulation of
Scd1, in that reducing the severity of colitis.This may also related
with significantly lower plasma and hepatic levels of cancer
marker-Saa1 in DSSPAR mice.
During inflammation, a large number of immune cells are
recruited to inflammatory lesions. Cell migration, phagocyto-
sis, bacteria killing and stimulated cell proliferation have high
energy demands (Borregaard & Herlin, 1982). Neutrophils, mac-
rophages, and dendritic cells primarily use glycolytic pathways
to obtain energy, whereas B andT cells use mainly amino acids,
glucose and lipids to generate energy during oxidative phos-
phorylation.The metabolome analysis revealed that compared
to DSS group, PAR induced significant decreases in plasma
amino acids related to pyruvate (Ala, Ser and Thr), oxaloac-
etate (Asn and Asp), and succinyl coA (Met,Val and Isoleucine),
which are elements of the citric cycle. Total glucogenic amino
acids were also significantly reduced by PAR dietary interven-
tion. These indicate impaired glycolysis and oxidative
phosphorylation manifested by reduced inflammation in the
DSSPAR group. In addition, as an inflammatory marker of neu-
trophil activation, PAR dietary intervention tended (p = 0.09) to
improve elevated MPO levels induced by DSS administration
(CON: 5.9 ± 2.3 mU/mL; DSS: 13.3 ± 4.0 mU/mL; PAR 6.9 ± 2.0 mU/
mL). Our evaluation of the hepatic transcriptome coupled with
RT-PCR validation also indicated that PAR supplementation
induced a significant up-regulation of genes involved in the
intermediates of citric cycle—Fas, Me1, Scd1 and Elovl6. The
metabolic shifts in the citric cycle as well as the up-regulation
of fatty acid synthesis related genes could be reflected in the
improved body weight loss and relative mesenteric fat in the
DSSPAR mice.
IBD patients often present with a negative nitrogen balance,
and arginine (Arg), which is a semi-essential amino acid that
is important in protein synthesis, plays a key role in the in-
termediate metabolism of nitrogen by participating in the urea
cycle.Arg is also a substrate for nitric oxide (Coman, Yaplito-Lee,
& Boneh, 2008) and a precursor to glutamine, proline, and or-
nithine (Wu &Morris, 1998).The expression level of Arg1, which
is involved in the conversion of arginine to urea and arginine
to orthinine, was significantly decreased in the liver of DSSPAR
mice, which may explain the lower levels of urea in the liver,
and of arginine and orthinine in their plasma.As such, the ame-
liorative properties of PAR in colitis may be in part due to an
improved nitrogen balance in the liver, contributing to reduced
oxidative stress.
Inflammatory responses in the colon are accompanied by
striking shifts in tissue metabolism with respect to cellular
methylation reactions (Kominsky et al., 2011). In DSSPAR group,
we observed a significant down-regulation of Mat2a, the gene
that encodes for Mat2a—the enzyme responsible for the pro-
duction of S-adenosylmethionine, which is the methyl donor
for the majority of methylation reactions. A metabolite down-
stream of S-adenosylhomocysteine, cystathionine, as well as
a related enzyme, cystathionine gamma-lyase from proteome
were significantly down-regulated, indicating a shift to meth-
ylation inhibition may have occurred in the PAR-supplemented
mice. Cystathionine is converted into cysteine by cystathio-
nine gamma-lyase. The indirect increased biosynthesis of
cysteine (a precursor of glutathione) is an indication of the oxi-
dative stress state in the inflamed gastrointestinal tract (Miller
et al., 2013). In addition, riboflavin metabolism, which is re-
quired to convert glutathione between its oxidized and reduced
forms, is increased during inflammation. Both riboflavin and
NADPH, a product of the pentose phosphate pathway, are nec-
essary for regenerating oxidized glutathione back to its reduced
form, and are thus essential for pH and oxidative stress ho-
meostasis (Massey, 2000). The recovery of oxidative stress in
DSSPAR mice was complemented by the significant improve-
ment in NADH/NAD+ by PAR supplementation (Massudi, Grant,
Guillemin, & Braidy, 2012). This effect could be due in part to
the high concentrations of riboflavin in PAR (Supplementary
Table S7) which may compensate for increased riboflavin me-
tabolism during inflammation.
5. Conclusions
Through our nutriomics study, we have accumulated robust
scientific knowledge of nutrient signals and the imprint of PAR
on systems biology.The nutrition-relevant colon transcriptome
revealed a decrease in the expression of inflammatory cytokines
and fibrotic markers, resulting in reduced inflammation and
improved colon shortening. The dietary signature of PAR on
the hepatic transcriptome and proteome, which is comple-
mentary to that of the metabolome, showed a decrease in the
expression of carcinogenic markers, thereby reducing cancer
risk; increases in the expression of fatty acid synthesis-
related markers, thereby improving body weight loss; an up-
regulation of molecules involved in the citric acid cycle and
urea cycle suggesting recovery in both glycolysis and oxida-
tive stress. Markers in the methionine-recycling pathway were
down-regulated resulting in a shift to methylation inhibition
and reduced inflammation. The clues from each analysis
complement each other, completing the PAR-colitis puzzle, suc-
cessfully leading to the crucial findings of the present study
(Fig. 5).
Our study is a pioneering effort to obtain a precise under-
standing of PAR as a novel and effective nutraceutical in optimal
IBD management using multifaceted integrated omics analy-
ses. Our unique synergistic approach is of significant importance
since no single omics approach can fully illustrate the intri-
cate beauty behind the relatively modest influence of food
factors.We sincerely anticipate that the methods of this study
will serve as a clarion call to promote integrated omics nutri-
tion research to uncover new dietary intervention strategies
designed to recover normal homeostasis in disease states and
to maintain healthy well-being, bringing forward a new evo-
lution in nutritional science.
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